Compound Summary
Compound Information
化合物待补充
药名: | Eupachlorin acetate |
别名: | enoxaparin;nadroparin |
分子式: | C22H27ClO8 |
Smiles: | [C@]12([H])[C@](O[H])(C(C([H])([H])[H])=C([H])[C@@]1([H])OC(=O)C([H])([H])[H])[C@]3([H])[C@]([H])(C(=C([H])[H])C(=O)O3)[C@]([H])(OC(=O)\C(\C([H])([H])[H])=C([H])/C([H])([H])[H])C([H])([H])[C@]2(O[H])C ([H])([H])Cl |
成分: | HBIN029056 |
TCMID_id: | 23072;23123;23068 |
PubChem_id: | 772 |
化合物对应的植物
| 植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
|---|
| TCMBANKHE006865/YEM-745/XU-411 | Gardenia jasminoides var. grandiflora|Gardenia jasminoides(L.)Ellis|Gardenia jasminoides | 水蛭|栀子 | 栀子 | 云南民族药物志：第四卷|广东省廉江市石岭镇 | To clear heat and resolve toxin, disperse swelling and relieve pain./Heat toxin, jaundice, nosebleed(epistaxis), nephritis with edema, sprain and contusion. | 阿昌族/布依族/傣族/德昂族/景颇族/傈僳族/苗族/水族/瑶族/彝族/壮族 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
化合物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE000118 | CAPN2 | CANP2; CANPL2; CANPml; mCANP | calpain 2 |
| TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
| TCMBANKGE000251 | FGF2 | BFGF; FGF-2; FGFB; HBGF-2 | fibroblast growth factor 2 |
| TCMBANKGE000326 | SELP | CD62; CD62P; GMP140; GRMP; LECAM3; PADGEM; PSEL | selectin P |
| TCMBANKGE000335 | ITPR1 | ACV; CLA4; INSP3R1; IP3R; IP3R1; PPP1R94; SCA15; SCA16; SCA29 | inositol 1,4,5-trisphosphate receptor type 1 |
| TCMBANKGE000345 | ELK1 | - | ETS transcription factor ELK1 |
| TCMBANKGE000479 | TIMP1 | CLGI; EPA; EPO; HCI; TIMP; TIMP-1 | TIMP metallopeptidase inhibitor 1 |
| TCMBANKGE000521 | PLCG1 | NCKAP3; PLC-II; PLC1; PLC148; PLCgamma1 | phospholipase C gamma 1 |
| TCMBANKGE000681 | TNFRSF11B | OCIF; OPG; PDB5; TR1 | TNF receptor superfamily member 11b |
| TCMBANKGE000846 | MMP14 | MMP-14; MMP-X1; MT-MMP; MT-MMP 1; MT1-MMP; MT1MMP; MTMMP1; WNCHRS | matrix metallopeptidase 14 |
| TCMBANKGE000866 | PRKCB | PKC-beta; PKCB; PKCI(2); PKCbeta; PRKCB1; PRKCB2 | protein kinase C beta |
| TCMBANKGE000882 | SERPINE1 | PAI; PAI-1; PAI1; PLANH1 | serpin family E member 1 |
| TCMBANKGE000884 | FN1 | CIG; ED-B; FINC; FN; FNZ; GFND; GFND2; LETS; MSF; SMDCF | fibronectin 1 |
| TCMBANKGE000898 | MYC | MRTL; MYCC; bHLHe39; c-Myc | MYC proto-oncogene, bHLH transcription factor |
| TCMBANKGE000915 | BMPR2 | BMPR-II; BMPR3; BMR2; BRK-3; POVD1; PPH1; T-ALK | bone morphogenetic protein receptor type 2 |
| TCMBANKGE000938 | CDK2 | CDKN2; p33(CDK2) | cyclin dependent kinase 2 |
| TCMBANKGE000990 | EGFR | ERBB; ERBB1; HER1; NISBD2; PIG61; mENA | epidermal growth factor receptor |
| TCMBANKGE001107 | NOS3 | ECNOS; eNOS | nitric oxide synthase 3 |
| TCMBANKGE001113 | ACTA2 | ACTSA | actin alpha 2, smooth muscle |
| TCMBANKGE001132 | BAX | BCL2L4 | BCL2 associated X, apoptosis regulator |
| TCMBANKGE001148 | VEGFA | MVCD1; VEGF; VPF | vascular endothelial growth factor A |
| TCMBANKGE001162 | IFNG | IFG; IFI | interferon gamma |
| TCMBANKGE001166 | BCL2 | Bcl-2; PPP1R50 | BCL2 apoptosis regulator |
| TCMBANKGE001181 | TGFB1 | CED; DPD1; IBDIMDE; LAP; TGF-beta1; TGFB; TGFbeta | transforming growth factor beta 1 |
| TCMBANKGE001184 | RELA | CMCU; NFKB3; p65 | RELA proto-oncogene, NF-kB subunit |
| TCMBANKGE001197 | FOS | AP-1; C-FOS; p55 | Fos proto-oncogene, AP-1 transcription factor subunit |
| TCMBANKGE001966 | RASGRF2 | GRF2; RAS-GRF2 | Ras protein specific guanine nucleotide releasing factor 2 |
| TCMBANKGE002423 | XYLT1 | DBQD2; PXYLT1; XT-I; XT1; XTI; XYLTI; xylT-I | xylosyltransferase 1 |
| TCMBANKGE002442 | NT5E | CALJA; CD73; E5NT; NT; NT5; NTE; eN; eNT | 5'-nucleotidase ecto |
| TCMBANKGE003095 | F2RL1 | GPR11; PAR2 | F2R like trypsin receptor 1 |
| TCMBANKGE003300 | EIF6 | CAB; EIF3A; ITGB4BP; b(2)gcn; eIF-6; p27(BBP); p27BBP | eukaryotic translation initiation factor 6 |
| TCMBANKGE004004 | PRKDC | DNA-PKC; DNA-PKcs; DNAPK; DNAPKc; DNPK1; HYRC; HYRC1; IMD26; XRCC7; p350 | protein kinase, DNA-activated, catalytic subunit |
| TCMBANKGE006224 | PTGIR | IP; PRIPR | prostaglandin I2 receptor |
| TCMBANKGE006553 | PON1 | ESA; MVCD5; PON | paraoxonase 1 |
| TCMBANKGE006961 | F2 | PT; RPRGL2; THPH1 | coagulation factor II, thrombin |
| TCMBANKGE007151 | TIMP2 | CSC-21K; DDC8 | TIMP metallopeptidase inhibitor 2 |
| TCMBANKGE007361 | C1R | EDSPD1 | complement C1r |
| TCMBANKGE007665 | SPTAN1 | EIEE5; NEAS; SPTA2 | spectrin alpha, non-erythrocytic 1 |
| TCMBANKGE007836 | SELL | CD62L; LAM1; LECAM1; LEU8; LNHR; LSEL; LYAM1; PLNHR; TQ1 | selectin L |
| TCMBANKGE008481 | VWF | F8VWF; VWD | von Willebrand factor |
| TCMBANKGE008521 | GALNS | GALNAC6S; GAS; GalN6S; MPS4A | galactosamine (N-acetyl)-6-sulfatase |
| TCMBANKGE008670 | PIP4K2A | PI5P4KA; PIP5K2A; PIP5KII-alpha; PIP5KIIA; PIPK | phosphatidylinositol-5-phosphate 4-kinase type 2 alpha |
| TCMBANKGE008749 | PIP5K1A | - | phosphatidylinositol-4-phosphate 5-kinase type 1 alpha |
| TCMBANKGE008857 | LPL | HDLCQ11; LIPD | lipoprotein lipase |
| TCMBANKGE009342 | F10 | FX; FXA | coagulation factor X |
| TCMBANKGE009727 | ITGA2B | BDPLT16; BDPLT2; CD41; CD41B; GP2B; GPIIb; GT; GTA; HPA3; PPP1R93 | integrin subunit alpha 2b |
| TCMBANKGE012461 | HPSE | HPA; HPA1; HPR1; HPSE1; HSE1 | heparanase |
| TCMBANKGE013299 | F3 | CD142; TF; TFA | coagulation factor III, tissue factor |
| TCMBANKGE013920 | PCOLCE | PCPE; PCPE-1; PCPE1 | procollagen C-endopeptidase enhancer |
| TCMBANKGE014151 | ZBTB7A | FBI-1; FBI1; LRF; TIP21; ZBTB7; ZNF857A; pokemon | zinc finger and BTB domain containing 7A |
| TCMBANKGE014536 | DUSP22 | JKAP; JSP-1; JSP1; LMW-DSP2; LMWDSP2; MKP-x; MKPX; VHX | dual specificity phosphatase 22 |
| TCMBANKGE014626 | FGF10 | - | fibroblast growth factor 10 |
滇ICP备16009434号-1 |
Dai SX Lab